Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Your new treatment program will inform therapy
The timeline for these individuals will be on the longest end of the spectrum, often requiring more than 8-12 weeks to see significant results
Injectable GHK-Cu is not FDA-approved for human/therapeutic use and is sold by suppliers under "research use only" labeling
Larger, multicenter trials with balanced cohorts and extended follow-up are required to confirm comparative effects on HbA1c sustainability, beta-cell preservation, and insulin sensitivity
Presented for research literature review only Davis FC (1997)
Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Stancic Rokotov, D., Brcic, L., & Sebecic, B
US$ 22.36
US$ 28.89
US$ 26.52
US$ 22.79
US$ 22.30
US$ 23.46
US$ 21.45
US$ 21.98
